Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Avinash Kambadakone Ramesh, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Avinash Kambadakone Ramesh and Thomas Abrams.
Avinash Kambadakone Ramesh
Connection Strength
0.075
Thomas Abrams
  1. A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma. Clin Cancer Res. 2019 01 01; 25(1):80-89.
    View in: PubMed
    Score: 0.049
  2. Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol. 2010 Jan; 11(1):48-54.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.